Ligand Pharmaceuticals Inc., 10% Owner at Viking Therapeutics, Inc. (VKTX), sold 525,762 shares at $19.15 ($10.1M) on 2018-09-25, disclosed to the SEC on 2018-09-27.
Open-market sale of $10.1M VKTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.15 | 262,881 | $5.0M | 50.0% |
| 2 | $19.15 | 262,881 | $5.0M | 50.0% |
| Total | $19.15 avg | 525,762 | $10.1M | 100% |
| Filing → |